RecruitingNot ApplicableNCT05645575

In-patient SCC TMS

Pilot Study: Evaluating the Feasibility of Accelerated rTMS Treatment Delivered at Individual Resonant Frequencies for In-patient Subjects Suffering From Major Depressive Disorder


Sponsor

University of California, Los Angeles

Enrollment

30 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators are studying the feasibility, safety, and tolerability of administering accelerated repetitive Transcranial magnetic stimulation(a-rTMS) at frequencies other than standard 10 Hz for in-patient Subjects diagnosed with Major Depressive Disorder. Participants will be recruited from the Resnick Neuropsychiatric Hospital. This study will enroll 30 participants who will undergo up to three brain activity recordings, one MRI scan, one TMS procedure to determine the appropriate frequency and intensity for treatment, daily symptom assessments, and 25 TMS treatments. Participants will be asked to participate for up to 2 weeks.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing an intensive form of brain stimulation called accelerated TMS (transcranial magnetic stimulation) for people who are hospitalized with severe, treatment-resistant depression that has not responded to multiple antidepressants or other therapies. **You may be eligible if...** - You are between 18 and 65 years old - You have moderate to severe major depressive disorder (a HAM-D score of 17 or higher) - You have tried and not responded to at least 2 different antidepressant medications from at least 2 different drug classes - You have also tried at least two augmentation strategies and an adequate course of psychotherapy - You are currently hospitalized and able to follow an intensive treatment schedule **You may NOT be eligible if...** - You have a metal implant in or near your head (e.g., aneurysm clip) or another contraindication to TMS - You have a history of seizures, bipolar disorder, or a psychotic disorder - You are unable to give informed consent - You have an active infection or other serious medical condition Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEOpen-label TMS

Customized, Open-Label Transcranial Magnetic Stimulation


Locations(1)

UCLA TMS Service and Research Service

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05645575


Related Trials